In addition to the pancreas, accumulating evidence suggests the brain as another important GLP-1 responsive organ that can mediate GLP-1’s anti-obesity actions (Beiroa et al., 2014; Secher et al., 2014; Sisley et al., 2014; Smith et al., 2019). The gene discussed is GCG; the disease is Obesity.